MARISSA BOTHUN: Open Payments
NPI 1942507207 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,015 in 150 payments from 23 companies in 2025. Trend: 2023 $2,721 · 2024 $3,289 · 2025 $3,015
Food & beverage: $2,612Education: $403
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $498 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $446 |
| Regeneron Healthcare Solutions, Inc. | 13 | $323 |
| UCB, Inc. | 15 | $310 |
| Galderma Laboratories, L.P. | 16 | $180 |
| Arcutis Biotherapeutics, Inc. | 20 | $167 |
| GENZYME CORPORATION | 10 | $143 |
| Lilly USA, LLC | 5 | $131 |
| Incyte Corporation | 5 | $120 |
| E.R. Squibb & Sons, L.L.C. | 5 | $98 |
Products named: DUPIXENT, TREMFYA, Bimzelx, ILUMYA, Zoryve, NEMLUVIO, OPZELURA, Winlevi.
Industry payments across TX — which companies pay providers there.
